Low-Dose Weekly vs High-Dose Cisplatin
common.study.values.description
“Low-Dose Weekly vs High-Dose Cisplatin”
This study is a prospective open-label randomized clinical trial. Following informed consent eligible LASCCHN patients (n=100) planned for CRT will be stratified by tumor p16 status and then randomized in a 1:1 fashion to either concurrent HD cisplatin or concurrent weekly LD cisplatin.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-yes
Drug - High-Dose Cisplatin
Intravenous administration of High-Dose Cisplatin
Drug - Low-Dose Cisplatin
Intravenous administration of Low-Dose Cisplatin
Radiation - Radiotherapy
Participating centres are to follow their local radiation treatment planning and delivery techniques.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Randomized Trial Comparing Low-Dose Weekly to High-Dose Cisplatin Concurrent With Radiation for Locally Advanced Head and Neck Cancer.
common.study.values.clinical-trial-id
NCT03649048
participant.views.study.view.id
dNkLpe
